Volume : 09, Issue : 06, June – 2022



Authors :

Dr. V. Sireesha*, M. Pratibha , M. Sunil Kumar , Aila Anusha , CH Kanna Reddy

Abstract :

COVID-19, in most patients, presents with mild flu-like illness. Elderly patients with comorbidities, like hypertension, diabetes, or lung and cardiac disease, are more likely to have severe disease and deaths. Neurological complications have emerged as a significant cause of morbidity and mortality in the ongoing COVID-19 pandemic. Beside respiratory insufficiency, many hospitalized patients exhibit neurological manifestations ranging from headache and loss of smell, to confusion and disabling strokes. COVID-19 is also anticipated to take a toll on the nervous system in the long term. Neurological complications are frequently reported in critically ill patients with comorbidities. In COVID-19, both central and peripheral nervous systems can be affected. The SARS-CoV-2 virus causes the disease COVID-19 and has the potential to invade the brain. The SARS-CoV-2 virus enters the brain either via a haematogenous route or olfactory system. The most severe neurological manifestations, altered sensorium (agitation, delirium, and coma), are because of hypoxic and metabolic abnormalities. Characteristic cytokine storm incites severe metabolic changes and multiple organ failure. Profound coagulopathies may manifest with ischemic or haemorrhagic stroke. Rarely, SARS-CoV-2 virus encephalitis like acute disseminated encephalomyelitis or acute necrotizing encephalopathy have been reported. Complete or partial anosmia and ageusia are common peripheral nervous system manifestations. Recently, many cases of Guillain-Barré syndrome in COVID-19 patients have been observed, and a postinfectious immune-mediated inflammatory process was held responsible for this. Myalgia/fatigue is also common, and elevated creatine kinase levels indicate muscle injury. Here, we will provide a critical appraisal of the potential for neurotropism and mechanisms of neuropathogenesis of SARS-CoV-2 as they relate to the acute and chronic neurological consequences of the infection. Finally, we will examine potential avenues for future research and therapeutic development. Due to its worldwide distribution and multifactorial pathogenic mechanisms, COVID-19 poses a global threat to the entire nervous system. Although our understanding of SARS-CoV-2 neuropathogenesis is still incomplete and our knowledge is evolving rapidly, we hope that this review will provide a useful framework and help neurologists in understanding the many neurologic facets of COVID-19.
Keywords: Coronavirus; Guillain-Barre syndrome; encephalitis; encephalopathy; myalgia

Cite This Article:

Please cite this article in press V. Sireehsa et al, Review On Effect Of Covid 19 On Nervous System., Indo Am. J. P. Sci, 2022; 09(6).,

Number of Downloads : 10


1. https://www.webmd.com/lung/coronavirus.
2. https://www.reddit.com/user/Nursing_UCG/comments/u115fb/coronavirus_and_covid19.
3. Costantino ladecola, Josef Anrather, Hooman Kamel. Effects of covid-19 on the nervous system. Feli family.brain and mind research institute vol.183.
4. Sachdev, Kriti, Agrawal, Sumita, Ish, Pranav, Gupta.Neurological manifestations of covid-19 A brief review.Indian Journal of medical research vol.152-2020.
5. Nitesh, Raheja, Kapil. Neurological manifestations of covid-19 A brief review.Indian Journal of medical research.2020.
6. Maura,Boldrini, Peter D.Canoll.How covid-19 affects the brain. JAMA Psychiatry.2021;vol-78.

7. Robyn S,Klein. How covid-19 affects the brain. JAMA Psychiatry.2021.
8. ladecola ,Josef ,Hoomankamal.Effects of COVID-19 on the Nervous .Volume 183, Issue .1 October 2020,Pages 16-27.
9. Costantino Iadecola,Josef Anrather and Hooman Kamel.Effects of COVID-19 on the Nervous System.2020.08.028.
10. Yeshun Wu,Xiaolin Xu,Zijun Chen,Jiahao Duan,Kenji Hashimoto,Ling Yang,Cunming Liu,Chun Yang.Nervous system involvement after infection with COVID-19 and other coronaviruses.brain, Behavior and immunity 87 (2020) 18-22.
11. Michael Marshall.How Covid-19 can “The neurological symptoms are only becoming more and more scary,” says Alysson Muotri, a neuroscientist at the University of California, San Diego, in La Jolla.17 September 2020. Vol 585.
12. Giamarellos-Bourboulis, Evangelos J. “Complex Immune Dysregulation in Coid-19 patients with severe respiratory failure.” Cell host & Microbe, Vol. 27, No. 6, pp.992-1000
13. Mouhamed Yazan Abou-Ismail,Akiva Diamond,Sargam Kapoor,Yasmin Arafah and Lalitha Nayak.The hypercoagulable state in COVID-19.2020 Jun 20.
14. Yeshun Wu, Xiaolin Xu, Zijun Chen, Duan, Kenji Hashimoto, Ling Yang, Cunming Liu, Chun Yang.Nervous system involvement after infection with COVID-19 and other coronaviruses. brain, Behavior and immunity 87 (2020) 18-22.
15. Abbas Jarrahi,Meenakshi Ahluwalia,Hesam Khodadadi , Evila da Silva Lopes Salles , Ravindra Kolhe, David C.Hess, Fernando Vale, Manish Kumar, Babak Baban, Kumar Vaibhav and Krishnan M,Dhandapani.Neurological consequences of COVID-19. Jarrahi et al Neuroinflammation (2020) 17:286.
16. Ishita Desai, Rajat Manchanda,Niraj Kumar. Neurological manifestations of coronavirus disease 2019.2021 Jan 11.
17. Ravindra K Garg.Spectrum of Neurological Manifestations in Covid-19 of Neurological .6-Jul-2020.
18. Ashutosh Tiwari and Mritunjai Kumar. Neurological manifestations of coronavirus disease 2019.
19. Juan I. Guerrero,Luis A. Barragán, Juan D. Martínez,Juan P. Montoya, Alejandra Peña, Fidel E. Sobrino, Zulma Tovar-Spinoza, and Kemel A.Ghotme Central and peripheral nervous system involvement by COVID-19. 2021 Jun 2.
20. Niraj Kumar Jha, Shreesh Ojha, Saurabh Kumar Jha, Harish Dureja, Sachin Kumar Singh,Shakti, Shukla, Dinesh Kumar Chellappan,Gaurav Gupta,Shanu Bhardwaj,Neeraj Kumar,Madhan Jeyaraman, Rashmi Jain, Sathish Muthu, Rohan Kar,Dhruv Kumar,Vineet Kumar Goswami,Janne Ruokolainen, Kavindra Kumar Kesari,Sandeep Kumar Singh, Kamal Dua.Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS‐CoV‐2 in the Nervous System: A Review on Neurological Impairments and Manifestations.27 November 2020.
21. Lawrence Langley,Claudia Zeicu,Louise Whitton,Mathilde Pauls.Acute disseminated encephalomyelitis (ADEM) associated with COVID-19.BMJ case reports.2022.
22. Acute Disseminated Encephalomyelitis (ADEM) | Diagnosis.” SRNA, 24 Oct. 2019
23. Mouhamed Yazan Abou-Ismail,Akiva Diamond,Sargam Kapoor,Yasmin Arafah and Lalitha Nayak.The hypercoagulable state in COVID-19.2020 Jun 20.
24. COVID-19-Associated Coagulopathy.” Dynamed.com, 2022, www.dynamed.com/management/covid-19-associated-coagulopathy.2020
25. Shahjouei, Shima, et al. “SARS-CoV-2 and Stroke Characteristics.” Stroke, vol. 52, no. 5, May 2021, 10.1161/strokeaha.120.032927.
26. Panagis Galiatsatos, M.H.S, Robert Brodsky. Coronavirus Blood Clots. March 3, 2022.
27. NHS Choices. “Diagnosis – Stroke.” NHS, 15 Aug. 2019.
28. NHS Choices. “Treatment – Stroke.” NHS, 2019.
29. Gaurav Nepal, Jessica Holly Rehrig, Gentle Sunder Shrestha. Neurological manifestations of COVID-19. 13 July 2020.
30. Weng LM, Su X, Wang XQ. Pain Symptoms in Patients with Coronavirus Disease (COVID-19).26 January 2021 Volume 2021:14 Pages 147-159.
31. Stephani Sutherland.Neurological symptoms might arise from multiple causes.October 22, 2020.
32. Sasan Andalib,Jose biller,Mario de Napoli.Peripheral Nervous System Manifestations Associated with COVID-19.Springer nature.2021.
33. Yow Ka Shing,Jayant Kumar Yadav,Rajeev Ojha,Gaurab Pokhrel,Zhi Lan Tu & Dong Ya Huang . Neurological manifestations of COVID-19. 13 July 2020.
34. Shahrzad Shoraka, Maria Lucia Brito Ferreira, Seyed Reza Mohebbi and Amir Ghaemi.SARS-CoV-2 Infection and Guillain-Barré Syndrome.2021 May 10.
35. Moriguchi, T. et al. Int. J. Infect. Dis. (2020). 94, 55–58.
36. James E.Goldman Professor of pathology & cell biology (in psychiatry), who led the study with Peter D. Canoll.Professor of pathology & cell biology, and Kiran T. Thakur.SARS-CoV-2 does not directly infect the brain but can still inflict significant neurological damage.April 18,2021.
37. Finsterer, Josef, et al. “COVID-19 Associated Cranial Nerve Neuropathy: A Systematic Review.” Bosnian Journal of Basic Medical Sciences, vol. 22, no. 1, 11 Aug. 2021, 10.17305/bjbms.2021.6341.
38. Carlos Salama,Jian Han,Linda Yau,William G. Reiss,Benjamin Kramer,Jeffrey D. Neidhart,Gerard J. Criner,Emma Kaplan-Lewis, Rachel Baden,Lavannya Pandit,Miriam L. Cameron,Julia Garcia-Diaz,Victoria Chávez,Martha Mekebeb-Reuter,Ferdinando Lima de Menezes,Reena Shah, F.R.C.P., Maria F. González-Lara, Beverly Assman,Jamie Freedman and Shalini V. Mohan.Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. January 7, 2021.
39. Tang, Yujun, et al. “Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies.” Frontiers in Immunology.2020;11:1708.
40. ladecola ,Josef ,Hoomankamal.Effects of COVID-19 on the Nervous .Volume 183, Issue .1 October 2020,Pages 16-27.